Skip to main content
. 2018 May 8;8:7137. doi: 10.1038/s41598-018-25552-z

Figure 3.

Figure 3

PCA score plots of metabolic profiles in early-stage NSCLC patients and HC with or without mean-centred (ctr) scaling. (A) UHPLC-Q-TOF/MS analysis in the positive mode, R2X = 0.627. (B) UHPLC-Q-TOF/MS analysis in the negative mode, R2X = 0.529. (C) GC-TOF/MS analysis, R2X = 0.416. Dots and boxes denote samples from early-stage NSCLC patient and HC, respectively.